All In MedTech

Device Trial Radar · NCT07558395

Effectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour

Last checked: Nov 19, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

120

Planned (sponsor's estimate)

Start

Dec 2026

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Sponsor type
Government (non-federal)
Collaborators
Fight Kids Cancer
First posted
Apr 30, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Other
FDA-regulated device
No
Who can join
All sexes, from 10 years, up to 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluate the efficiency of audiovisual stimulation in virtual reality for improving the visual perception of children, adolescents, and young adults with hemianopia resulting from pediatric brain tumors. These individuals can lose up to 50% of their visual field, significantly impacting their independence, mobility, and daily lives.

Conditions

  • Hemianopsia
  • Virtual Reality
  • Visual Rehabilitation
  • Pediatric Brain Tumor

Interventions

  • Visual StimulationDevice

    Our audiovisual stimulation procedure IVR, called 3D-MOT, was encoded using the the 3D Unity programming platform and deployed in HMDs with built-in head/eye tracking. We implemented the multiple object tracking (MOT) paradigm, developed in the 80's to study visual attention in humans, and added correlated spatial sound.

  • standard of careOther

    During this phase, the patients will be at home without a headset and will not be exposed to an audio-visual stimulation task in virtual reality.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Visual field perimetry measured using the Esterman binocular field testTime frame: From enrollment to the end of follow up period at 6 months

Locations

8 sites in 7 countries. Site status is shown where the registry gives one.

  • Department of Paediatric and adolescents medicine, Medical University

    Vienna, Austria

  • Paediatrics and Adolescents Medicine, University Hospital

    Copenhagen, Denmark

  • Hôpital de Hautepierre

    Strasbourg, France

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.